Trifluridine/tipiracil in patients with metastatic gastroesophageal junction cancer : a subgroup analysis from the phase 3 TAGS study
-
Mansoor, Wasat (The Christie NHS Foundation Trust)
;
Arkenau, Hendrik-Tobias (University College London) ;
Alsina, Maria (Vall d'Hebron Institut d'Oncologia) ;
Shitara, Kohei (National Cancer Center Hospital East) ;
Thuss-Patience, Peter (Charité - Universitätsmedizin Berlin) ;
Cuffe, Sinead (St. James's Hospital ( Dublín, Irlanda)) ;
Dvorkin, Mikhail (Omsk Regional Clinical Centre of Oncology) ;
Park, David (St, Joseph Heritage Healthcare) ;
Ando, Takayuki (University of Toyama) ;
Van Den Eynde, Marc (UCL Cliniques Universitaires Saint-Luc) ;
Beretta, Giordano D. (Humanitas Gavazzeni) ;
Zaniboni, Alberto (Fondazione Poliambulanza-Istituto Ospedaliero) ;
Doi, Toshihiko (National Cancer Center Hospital East) ;
Tabernero, Josep (Vall d'Hebron Institut d'Oncologia) ;
Ilson, David H. (Memorial Sloan Kettering Cancer Center) ;
Makris, Lukas (Stathmi, Inc, New Hope, PA USA) ;
Benhadji, Karim A. (Taiho Oncology) ;
Van Cutsem, Eric (University Hospitals Gasthuisberg (Leuven, Bélgica)) ;
Universitat Autònoma de Barcelona